|
Technology Platforms Therapy Nanoparticle biotechnology is the next generation of the technological revolution in drug delivery. Specifically, this technology has vast medical and pharmacological potential because, combined with gene therapy, it can target a host of medical conditions. TGN has developed a pioneering SiPlex™ technology, which combines nanoparticle-based delivery and RNA interference (siRNA) technologies under one platform. The unique attribute of SiPlex™ technology is that it knocks down the expression undesired genes and proteins and can be effective in developing drugs for viral infections, cancer and asthma. The key advantages are: 1) bio-compatibility and bio-degradability, 2) targeted delivery, 3) slow, sustained release of a gene or relevant drug, and 4) cost effectiveness. |
| |
|